Kilitch Drugs (India) Limited (KILITCH) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.025x

Based on the latest financial reports, Kilitch Drugs (India) Limited (KILITCH) has a cash flow conversion efficiency ratio of -0.025x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-66.20 Million ≈ $-715.95K USD) by net assets (Rs2.64 Billion ≈ $28.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see KILITCH company net worth for the company's overall valuation and market capitalisation.

Kilitch Drugs (India) Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Kilitch Drugs (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Kilitch Drugs (India) Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kilitch Drugs (India) Limited ranked by their cash flow conversion efficiency. Explore Kilitch Drugs (India) Limited cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
S Connect Co. LTD
KQ:096630
0.101x
Deutsch Motors Inc
KQ:067990
0.066x
Thanh Cong Textile Garment Investment Trading JSC
VN:TCM
0.042x
Future Vision II Acquisition Corporation Ordinary shares
NASDAQ:FVN
-0.270x
SEWON Precision Industry Co., Ltd.
KO:021820
-0.022x
The State Trading Corporation of India Limited
NSE:STCINDIA
0.000x
Arena Group Holdings Inc
NYSE MKT:AREN
-2.718x
Taeyang Metal
KO:004100
0.052x

Annual Cash Flow Conversion Efficiency for Kilitch Drugs (India) Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Kilitch Drugs (India) Limited from 2006 to 2025. View KILITCH share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs2.00 Billion
≈ $21.68 Million
Rs175.42 Million
≈ $1.90 Million
0.088x +10608.11%
2024-03-31 Rs1.76 Billion
≈ $19.00 Million
Rs-1.46 Million
≈ $-15.82K
-0.001x -104.85%
2023-03-31 Rs1.51 Billion
≈ $16.28 Million
Rs25.86 Million
≈ $279.64K
0.017x -58.34%
2022-03-31 Rs1.40 Billion
≈ $15.17 Million
Rs57.83 Million
≈ $625.41K
0.041x -88.31%
2021-03-31 Rs1.29 Billion
≈ $14.00 Million
Rs456.59 Million
≈ $4.94 Million
0.353x +1034.35%
2020-03-31 Rs1.20 Billion
≈ $13.03 Million
Rs37.45 Million
≈ $405.02K
0.031x +1216.09%
2019-03-31 Rs1.23 Billion
≈ $13.32 Million
Rs2.91 Million
≈ $31.46K
0.002x -81.28%
2018-03-31 Rs1.13 Billion
≈ $12.19 Million
Rs14.23 Million
≈ $153.90K
0.013x +13.89%
2017-03-31 Rs1.01 Billion
≈ $10.94 Million
Rs11.21 Million
≈ $121.28K
0.011x -93.01%
2016-03-31 Rs1.09 Billion
≈ $11.75 Million
Rs172.33 Million
≈ $1.86 Million
0.159x +349.49%
2015-03-31 Rs1.20 Billion
≈ $12.96 Million
Rs-76.18 Million
≈ $-823.90K
-0.064x +75.42%
2014-03-31 Rs1.20 Billion
≈ $13.00 Million
Rs-310.84 Million
≈ $-3.36 Million
-0.259x -2155.68%
2013-03-31 Rs1.19 Billion
≈ $12.88 Million
Rs14.97 Million
≈ $161.93K
0.013x +104.95%
2012-03-31 Rs1.16 Billion
≈ $12.50 Million
Rs-293.49 Million
≈ $-3.17 Million
-0.254x -217.16%
2011-03-31 Rs858.72 Million
≈ $9.29 Million
Rs186.05 Million
≈ $2.01 Million
0.217x +3.92%
2010-03-31 Rs740.88 Million
≈ $8.01 Million
Rs154.46 Million
≈ $1.67 Million
0.208x +27.83%
2009-03-31 Rs643.97 Million
≈ $6.96 Million
Rs105.03 Million
≈ $1.14 Million
0.163x +120.74%
2008-03-31 Rs513.18 Million
≈ $5.55 Million
Rs-403.48 Million
≈ $-4.36 Million
-0.786x -189.85%
2007-03-31 Rs135.84 Million
≈ $1.47 Million
Rs118.87 Million
≈ $1.29 Million
0.875x +22.51%
2006-03-31 Rs116.74 Million
≈ $1.26 Million
Rs83.39 Million
≈ $901.79K
0.714x --

About Kilitch Drugs (India) Limited

NSE:KILITCH India Drug Manufacturers - Specialty & Generic
Market Cap
$72.39 Million
Rs6.69 Billion INR
Market Cap Rank
#20566 Global
#1128 in India
Share Price
Rs191.45
Change (1 day)
+1.47%
52-Week Range
Rs124.45 - Rs400.25
All Time High
Rs487.85
About

Kilitch Drugs (India) Limited engages in the development and operation of the pharmaceutical business in India and internationally. The company offers various parenteral, nasal, and topical products, such as liquid ampoules, vials, dry powder injectables, and metered nasal drops for gastroenterology, non-steroidal anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, ant… Read more